Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The VEGFR2-Akt-eNOS pathway increases blood vessel formation
Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts
Location: Commonly found on the lips, mouth, or genital area
Coders must review clinical documentation carefully when coding different types of anemia to determine the appropriate classification, whether the condition is inherited or acquired, and whether an underlying diagnosis must be reported first
US$ 20.07
US$ 20.09
US$ 21.69
US$ 22.98
US$ 26.86
